Charles Lin, MD | |
900 Canton Ave, Baltimore, MD 21229 | |
(410) 368-3045 | |
(410) 951-4009 |
Full Name | Charles Lin |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 22 Years |
Location | 900 Canton Ave, Baltimore, Maryland |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1003853169 | NPI | - | NPPES |
454MN960 | Other | MD | TRAILBLAZER |
41012190 | Medicaid | MD |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | D0063996 (Maryland) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Mercy Medical Center Inc | Baltimore, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
North Calvert Anesthesiology Services Llc | 8921309980 | 49 |
News Archive
At first glance, Down syndrome and Alzheimer's disease, two severe brain abnormalities, may seem to have little in common. Down syndrome is a hereditary disease, the source of which has long been recognized-a triplication of chromosome 21.
VaxInnate Corporation today announced that enrollment has commenced in a Phase 1 clinical trial to evaluate VAX2012Q, a recombinant quadrivalent vaccine in development for the prevention of seasonal influenza. VaxInnate is a biotechnology firm pioneering a breakthrough technology platform for the development of novel vaccines.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
A University of Cincinnati (UC) physician is the lead author of new, simplified guidelines designed to help physicians treat and prevent heart attacks.
› Verified 7 days ago
Entity Name | North Calvert Anesthesiology Services Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1710360227 PECOS PAC ID: 8921309980 Enrollment ID: O20151216000559 |
News Archive
At first glance, Down syndrome and Alzheimer's disease, two severe brain abnormalities, may seem to have little in common. Down syndrome is a hereditary disease, the source of which has long been recognized-a triplication of chromosome 21.
VaxInnate Corporation today announced that enrollment has commenced in a Phase 1 clinical trial to evaluate VAX2012Q, a recombinant quadrivalent vaccine in development for the prevention of seasonal influenza. VaxInnate is a biotechnology firm pioneering a breakthrough technology platform for the development of novel vaccines.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
A University of Cincinnati (UC) physician is the lead author of new, simplified guidelines designed to help physicians treat and prevent heart attacks.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Charles Lin, MD 66 Powerhouse Rd, 3rd Floor, Roslyn Heights, NY 11577-1324 Ph: (516) 945-3000 | Charles Lin, MD 900 Canton Ave, Baltimore, MD 21229 Ph: (410) 368-3045 |
News Archive
At first glance, Down syndrome and Alzheimer's disease, two severe brain abnormalities, may seem to have little in common. Down syndrome is a hereditary disease, the source of which has long been recognized-a triplication of chromosome 21.
VaxInnate Corporation today announced that enrollment has commenced in a Phase 1 clinical trial to evaluate VAX2012Q, a recombinant quadrivalent vaccine in development for the prevention of seasonal influenza. VaxInnate is a biotechnology firm pioneering a breakthrough technology platform for the development of novel vaccines.
Boehringer Ingelheim Pharmaceuticals, Inc. will present new phase Ib data at the 2011 American Society of Clinical Oncology annual meeting in Chicago that indicates combining its investigational therapy afatinib with cetuximab at the maximum tested dose controlled disease in all (n=22) treated epidermal growth factor receptor (EGFR)-mutation positive patients with non-small cell lung cancer who developed acquired resistance to treatment with a reversible EGFR tyrosine kinase inhibitor.
A University of Cincinnati (UC) physician is the lead author of new, simplified guidelines designed to help physicians treat and prevent heart attacks.
› Verified 7 days ago
Kathryn Rosenblatt, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1800 Orleans St, Baltimore, MD 21287 Phone: 410-955-7461 Fax: 410-614-7903 | |
Dr. Tiffani Danielle Pittman, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5601 Loch Raven Blvd, Baltimore, MD 21239 Phone: 443-444-4863 Fax: 443-444-4997 | |
Aaron Sachs, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 22 S Greene St # S11c, University Of Maryland Department Of Anesthesia, Baltimore, MD 21201 Phone: 410-328-1239 | |
Dr. Mohamed Ehab Ramadan Mohamed Ramadan, MBBCH, MSC, PHD Anesthesiology Medicare: Medicare Enrolled Practice Location: 600 North Wolfe Street, Nelson 2-131, Baltimore, MD 21287 Phone: 410-955-1818 | |
Lynette Mark, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-6353 | |
Dr. Jasjit B Atwal, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 110 S Paca St, Suite 300 6th Fl, Baltimore, MD 21201 Phone: 410-328-6720 Fax: 410-328-1674 |